Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 29% ± 11% | |
retinal cone cell | 8 studies | 55% ± 19% | |
retinal rod cell | 8 studies | 51% ± 23% | |
type I pneumocyte | 6 studies | 25% ± 5% | |
endothelial cell | 5 studies | 18% ± 2% | |
retina horizontal cell | 5 studies | 28% ± 7% | |
cardiac muscle cell | 5 studies | 38% ± 8% | |
club cell | 5 studies | 24% ± 5% | |
epithelial cell | 4 studies | 39% ± 15% | |
brush cell | 4 studies | 29% ± 13% | |
goblet cell | 4 studies | 34% ± 26% | |
capillary endothelial cell | 3 studies | 23% ± 8% | |
enteroendocrine cell | 3 studies | 24% ± 7% | |
type II pneumocyte | 3 studies | 20% ± 3% | |
basal cell | 3 studies | 32% ± 14% | |
mucus secreting cell | 3 studies | 32% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 7 studies | 33% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 4362.07 | 244 / 245 | 100% | 17.43 | 502 / 502 |
esophagus | 99% | 2240.70 | 1434 / 1445 | 98% | 13.88 | 180 / 183 |
intestine | 99% | 3408.30 | 957 / 966 | 96% | 7.17 | 506 / 527 |
stomach | 99% | 3010.66 | 357 / 359 | 95% | 8.38 | 271 / 286 |
lung | 99% | 2717.02 | 575 / 578 | 87% | 5.83 | 1009 / 1155 |
bladder | 100% | 2097.29 | 21 / 21 | 86% | 5.63 | 435 / 504 |
uterus | 97% | 1504.88 | 165 / 170 | 86% | 7.24 | 395 / 459 |
breast | 78% | 2033.72 | 360 / 459 | 97% | 12.43 | 1089 / 1118 |
pancreas | 79% | 677.45 | 259 / 328 | 88% | 5.37 | 156 / 178 |
kidney | 100% | 1515.39 | 89 / 89 | 27% | 0.96 | 242 / 901 |
thymus | 95% | 912.93 | 618 / 653 | 21% | 0.80 | 130 / 605 |
ovary | 16% | 113.43 | 28 / 180 | 91% | 5.76 | 392 / 430 |
muscle | 100% | 3300.27 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.09 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 96% | 8.52 | 43 / 45 |
blood vessel | 95% | 1215.48 | 1265 / 1335 | 0% | 0 | 0 / 0 |
heart | 91% | 1764.10 | 786 / 861 | 0% | 0 | 0 / 0 |
skin | 72% | 6690.85 | 1305 / 1809 | 15% | 0.77 | 73 / 472 |
adrenal gland | 12% | 90.52 | 32 / 258 | 48% | 2.49 | 111 / 230 |
adipose | 45% | 351.82 | 544 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 0.99 | 8 / 29 |
spleen | 26% | 158.51 | 62 / 241 | 0% | 0 | 0 / 0 |
liver | 10% | 59.05 | 22 / 226 | 13% | 0.55 | 52 / 406 |
brain | 0% | 1.95 | 7 / 2642 | 15% | 0.53 | 107 / 705 |
peripheral blood | 14% | 95.95 | 126 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.29 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045664 | Biological process | regulation of neuron differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CASZ1 |
Protein name | Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) Castor zinc finger 1 |
Synonyms | SRG CST ZNF693 |
Description | FUNCTION: Transcriptional activator . Involved in vascular assembly and morphogenesis through direct transcriptional regulation of EGFL7 . . |
Accessions | Q86V15 K7EQC6 ENST00000344008.5 [Q86V15-2] ENST00000377022.8 [Q86V15-1] ENST00000447850.3 |